Melatech ApS

The Company's principal activities are to conduct a development, trade and service business within the health technology sector, as well as any business related hereto, at the Management's discretion.

Development in activities and financial and economic position

In 2025 Melatech continued building its platform for specialist support in primary care, augmented by hardware and administrative AI. Commercial revenue grew strongly, with the Danish businessremaining as the comapany’s profitable foundation. In Denmark the Company expanded to nearly 50% of the entire primary care sector, while advancing pilots and contracts in the United States and continuing early activity in Germany. As planned, the company recorded a net loss for the year, reflecting deliberate investment in platform expansion and new-market entry. Looking ahead, Melatech aims to further its activities through application expansion with a focus on Denmark and broad market expansion of our dermatological application.

Significant events after the end of the financial year

No events have occurred after the end of the financial year of material importance for the Company's financial position.

Lease liabilities

The company has entered into lease commitments which, at the balance sheet date, amount to DKK 745 thousand within the non-cancellable period, expiring on 15 December 2027

5 | Charges and securities

As security for a promissory note of DKK 990 thousand, the Company has granted a floating charge of a nominal amount of DKK 4,345 thousand. The floating charge comprises the following assets, whose carrying amounts at the balance sheet date are as follows:…

5 | Charges and securities

As security for a promissory note of DKK 990 thousand, the Company has granted a floating charge of a nominal amount of DKK 4,345 thousand. The floating charge comprises the following assets, whose carrying amounts at the balance sheet date are as follows:…